VIRGINIA C BROUDY
Medical Practice at 9 Ave, Seattle, WA
License number
Washington MD00022988
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
Washington MD00022988
Category
Medical Practice
Type
Hematology
Address
Address
325 9Th Ave, Seattle, WA 98104
Phone
(206) 731-3241
(206) 543-6420
(206) 543-6420
Personal information
See more information about VIRGINIA C BROUDY at radaris.comName
Address
Phone
2231 2Nd Ave, Seattle, WA 98121
2231 32Nd Ave S, Seattle, WA 98144
Organization information
See more information about VIRGINIA C BROUDY at bizstanding.comVirginia C Broudy MD
325 9 Ave, Seattle, WA 98104
Categories:
Internal Medicine Physicians & Surgeons
Phone:
(206) 744-3300 (Phone)
Professional information
Dr. Virginia C Broudy, Seattle WA - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Harborview Medical Cntr Hem Onc
325 9Th Ave, Seattle 98104
(206) 744-3300 (Phone)
325 9Th Ave, Seattle 98104
(206) 744-3300 (Phone)
Certifications:
Hematology, 1988, Internal Medicine, 1983, Medical Oncology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Harborview Medical Cntr Hem Onc
325 9Th Ave, Seattle 98104
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
325 9Th Ave, Seattle 98104
Harborview Medical Center
325 9Th Ave, Seattle 98104
University of Washington Medical Center
1959 East Pacific St, Seattle 98195
Education:
Medical School
University of California At San Francisco
Graduated: 1980
Oregon Health and Science University
University of California At San Francisco
Graduated: 1980
Oregon Health and Science University
Virginia C Broudy, Seattle WA
Specialties:
Hematologist
Address:
325 9Th Ave, Seattle, WA 98104
Education:
University of California San Francisco, School of Medicine - Doctor of Medicine*
OHSU Hospitals & Clinics - Fellowship - Hematology and Oncology (Internal Medicine)*
OHSU Hospitals & Clinics - Residency - Internal Medicine*
OHSU Hospitals & Clinics - Fellowship - Hematology and Oncology (Internal Medicine)*
OHSU Hospitals & Clinics - Residency - Internal Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)*
Virginia Constance Broudy, Seattle WA
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology, Hematology
Work:
Harborview Medical Center Hematology Oncology Clinic
325 9Th Ave, Seattle, WA 98104 University Of Washington Physicians
1959 Ne Pacific St, Seattle, WA 98195
325 9Th Ave, Seattle, WA 98104 University Of Washington Physicians
1959 Ne Pacific St, Seattle, WA 98195
Education:
University of California at Los Angeles (1980)
Hybridoma And Monoclonal Antibody Specific For Human Stem Cell Factor Receptor And Methods Of Use Of The Monoclonal Antibody For Detection Of Stem Cell Factor Receptors
US Patent:
5489516, Feb 6, 1996
Filed:
Jan 29, 1993
Appl. No.:
8/011078
Inventors:
Virginia C. Broudy - Seattle WA
Nancy Lin - Seattle WA
Nancy Lin - Seattle WA
Assignee:
Board of Regeant of the University of Washington - Seattle WA
International Classification:
G01N 3353, C12N 520, C07K 1630
US Classification:
435 723
Abstract:
The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as compositions containing such monoclonal antibodies and uses of such monoclonal antibodies in assays for detection of stem cell factor receptors in stem cell populations.
Monoclonal Antibodies To Stem Cell Factor Receptors
US Patent:
5919911, Jul 6, 1999
Filed:
Jun 5, 1995
Appl. No.:
8/462638
Inventors:
Virginia C. Broudy - Seattle WA
Nancy Lin - Seattle WA
Nancy Lin - Seattle WA
Assignee:
Board of Regents of the University of Washington - Seattle WA
International Classification:
A61K 39395
US Classification:
5303887
Abstract:
The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies.
Methods Of Purifying Hematopoietic Cells Using An Antibody To A Stem Cell Factor Receptor
US Patent:
5922847, Jul 13, 1999
Filed:
Jun 7, 1994
Appl. No.:
8/255193
Inventors:
Virginia C. Broudy - Seattle WA
Nancy Lin - Seattle WA
Nancy Lin - Seattle WA
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 3514, A61K 3944, C07K 122
US Classification:
530413
Abstract:
The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies.
Method Of Reconstituting Hematopoietic Cells Using Monoclonal Antibodies To The Stem Cell Factor Receptor
US Patent:
5906938, May 25, 1999
Filed:
May 24, 1995
Appl. No.:
8/449139
Inventors:
Virginia C. Broudy - Seattle WA
Nancy Lin - Seattle WA
Nancy Lin - Seattle WA
Assignee:
Board of Regents of the University of Washington - Seattle WA
International Classification:
C12N 1585
US Classification:
435372
Abstract:
The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies for the isolation and reconstitution of hematopoietic cells expressing the stem cell factor receptor.
Monoclonal Antibodies To Stem Cell Factor Receptors
US Patent:
2002001, Feb 14, 2002
Filed:
Jul 13, 1999
Appl. No.:
09/352466
Inventors:
VIRGINIA C BROUDY - SEATTLE WA, US
NANCY LIN - SEATTLE WA, US
NANCY LIN - SEATTLE WA, US
International Classification:
A01N001/00, A01N001/02, G01N033/53, C12P013/14, A61K039/395, A61K039/40, A61K039/42, A61K039/44, C07K016/00
US Classification:
424/130100, 435/001100, 435/007100, 435/002000, 424/141100, 424/144100, 424/153100, 424/156100, 424/178100, 530/387100
Abstract:
The present invention relates to monoclonal antibodies specific for a cell receptor specific for human stem cell factor (hSCF) as well as pharmaceutical compositions containing such monoclonal antibodies and uses of such monoclonal antibodies.